本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mirum Pharmaceuticals, Inc.

59.82
+6.4312.04%
盘后59.820.00000.00%19:57 EDT
成交量:204.67万
成交额:1.21亿
市值:29.63亿
市盈率:-49.55
高:61.00
开:55.25
低:54.75
收:53.39
52周最高:61.00
52周最低:36.86
股本:4,953.47万
流通股本:3,954.53万
量比:5.23
换手率:5.18%
股息:- -
股息率:- -
每股收益(TTM):-1.2073
每股收益(LYR):-1.8505
净资产收益率:-33.06%
总资产收益率:-7.11%
市净率:12.70
市盈率(LYR):-32.33

数据加载中...

2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/06

重要事件披露

Form 8-K - Current report
2025/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/30

重要事件披露

Form 8-K - Current report
2025/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/07

重要事件披露

Form 8-K - Current report
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/26

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]